Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2012
This study will test the clinical effectiveness and safety of apremilast compared with placebo as well as etanercept compared with placebo in the same group of patients with moderate to severe plaque psoriasis.
Epistemonikos ID: 09a60c2eb313f8e451b5a4411be63e7ee58dfa41
First added on: Feb 15, 2022